Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc.（SNDX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
sndx · 股价预测 · 22 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 22 位华尔街分析师
Buy
22 位分析师
共识
评级分布
12 个月目标价
High
$46.00
Consensus
$41.00
+141.7% upside
Low
$37.00
Median: $40 · Last Close: $16.96
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$41.00
141.7% upside
High Target
$46
171.2%
Low Target
$37
118.2%
Current Price
$16.96
as of today
Based on analyst price targets, the SNDX stock price prediction for the next 12 months ranges from $37 to $46. The consensus SNDX price forecast of $41.00 implies 141.7% upside from the current price of $16.96.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $16.11 | ↓ 5.00% |
1-day model range: $16.02–$16.21. Peak: $16.21 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $16 | -5.0% |
| 2028 | $16 | -7.6% |
| 2029 | $15 | -9.0% |
| 2030 | $15 | -9.7% |
| 2031 | — | -10.1% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SNDX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-13 | UBS | Maintains | Buy→Buy |
| 2026-05-01 | Barclays | Maintains | Overweight→Overweight |
| 2026-04-01 | Goldman Sachs | Maintains | Buy→Buy |
| 2026-03-31 | Mizuho | Maintains | Outperform→Outperform |
| 2026-03-09 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-03-02 | Citigroup | Maintains | Buy→Buy |
| 2026-01-27 | Mizuho | Maintains | Outperform→Outperform |
| 2025-12-09 | BTIG | Maintains | Buy→Buy |
| 2025-11-24 | Barclays | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Syndax Pharmaceuticals, Inc. (SNDX) stock. Of the recent 114 rating actions, 0 were upgrades and 2 were downgrades. 22 analysts currently cover SNDX.
分析师推荐趋势
SNDX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 3 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$345M
↓ 50.2% YoY
Revenue Next Year
$510M
↑ 47.5% YoY
EPS This Year
$-1.79
EPS Next Year
$-0.59
↓ 67.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast SNDX EPS of $-1.79 for the current fiscal year, based on estimates from 9 analysts. The SNDX revenue forecast is $345M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
SNDX 股价预测由两类独立数据源支撑：来自 22 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。SNDX 的共识目标价为 $41.00（+141.7% 上行空间），分析师共识为 Buy。
SNDX 的短期预测（明日）为 $16.11（-5.00%）。 SNDX 对 2027 年的股价预测均值为 $16。 SNDX 对 2030 年的预测区间为 $14–$16。
Syndax Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 SNDX。SNDX 在 2027 年的整体展望偏积极，在覆盖分析师中约 91% 对应 Buy 共识。
常见问题
SNDX 预测 · 8 个问题根据 22 位华尔街分析师，SNDX 的 12 个月平均目标价为 $41.00，最高 $46.00、最低 $37.00。若有图表，中位目标价可在上方查看。相对当前价 $16.96，隐含约 +141.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.